NanoString Technologies Receives $30,000,000 Series C Funding Round

  • Feed Type
  • Date
  • Company Name
    NanoString Technologies
  • Mailing Address
    530 Fairview Ave N Seattle, WA 98109
  • Company Description
    NanoString™ Technologies is developing a patent pending platform for single molecule identification and digital quantification. The NanoString™ system uniquely barcodes individual target molecules, scans them, and delivers a literal inventory of target molecules in the biological sample. This cutting-edge technology is a truly broad based platform onto which many applications can be developed, in life sciences or other industries entirely. Applications include gene expression analysis, proteomics, molecular diagnostics and, in the future, predictive, preventative, and personalized medicine.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series C
  • Proceeds Purposes
    NanoString’s new money will be used to help the company boost U.S. and international sales of nCounter, an instrument that’s supposed to give biologists a digital readout that says to what extent a given gene is dialed on or off in a tissue sample.
  • M&A Terms
  • Venture Investor
    Clarus Ventures
  • Venture Investor
    OVP Venture Partners
  • Venture Investor
    Draper Fisher Jurvetson

Trending on Xconomy